Suri Mohnish, Evers Jochem M G, Laskowski Roman A, O'Brien Sinead, Baker Kate, Clayton-Smith Jill, Dabir Tabib, Josifova Dragana, Joss Shelagh, Kerr Bronwyn, Kraus Alison, McEntagart Meriel, Morton Jenny, Smith Audrey, Splitt Miranda, Thornton Janet M, Wright Caroline F
Nottingham Regional Genetics ServiceNottingham University Hospitals NHS TrustCity Hospital Campus, The Gables, Hucknall RoadNottinghamNG5 1PBUK.
European Bioinformatics Institute (EMBL-EBI)Wellcome Genome Campus, HinxtonCambridgeCB10 1SDUK.
Mol Genet Genomic Med. 2017 Jun 20;5(5):495-507. doi: 10.1002/mgg3.304. eCollection 2017 Sep.
Syntaxin-binding protein 1, encoded by , is highly expressed in the brain and involved in fusing synaptic vesicles with the plasma membrane. Studies have shown that pathogenic loss-of-function variants in this gene result in various types of epilepsies, mostly beginning early in life. We were interested to model pathogenic missense variants on the protein structure to investigate the mechanism of pathogenicity and genotype-phenotype correlations.
We report 11 patients with pathogenic de novo mutations in identified in the first 4293 trios of the Deciphering Developmental Disorder (DDD) study, including six missense variants. We analyzed the structural locations of the pathogenic missense variants from this study and the literature, as well as population missense variants extracted from Exome Aggregation Consortium (ExAC).
Pathogenic variants are significantly more likely to occur at highly conserved locations than population variants, and be buried inside the protein domain. Pathogenic mutations are also more likely to destabilize the domain structure compared with population variants, increasing the proportion of (partially) unfolded domains that are prone to aggregation or degradation. We were unable to detect any genotype-phenotype correlation, but unlike previously reported cases, most of the DDD patients with pathogenic variants did not present with very early-onset or severe epilepsy and encephalopathy, though all have developmental delay with intellectual disability and most display behavioral problems and suffered seizures in later childhood.
Variants across that cause loss of function can result in severe intellectual disability with or without seizures, consistent with a haploinsufficiency mechanism. Pathogenic missense mutations act through destabilization of the protein domain, making it prone to aggregation or degradation. The presence or absence of early seizures may reflect ascertainment bias in the literature as well as the broad recruitment strategy of the DDD study.
Syntaxin结合蛋白1由[基因名称未给出]编码,在大脑中高度表达,并参与突触小泡与质膜的融合。研究表明,该基因的致病性功能丧失变异会导致各种类型的癫痫,大多在生命早期发病。我们有兴趣在蛋白质结构上模拟致病性错义变异,以研究其致病机制和基因型 - 表型相关性。
我们报告了在“解读发育障碍(DDD)”研究的前4293个三联体中鉴定出的11例携带[基因名称未给出]致病性新发突变的患者,其中包括6个错义变异。我们分析了本研究及文献中致病性错义变异的结构位置,以及从外显子聚合联盟(ExAC)提取的群体错义变异。
与群体变异相比,致病性变异更有可能出现在高度保守的位置,并且埋藏在蛋白质结构域内部。与群体变异相比,致病性突变也更有可能使结构域结构不稳定,增加(部分)未折叠结构域易于聚集或降解的比例。我们未能检测到任何基因型 - 表型相关性,但与先前报道的病例不同,大多数携带[基因名称未给出]致病性变异的DDD患者并未表现出非常早发或严重的癫痫和脑病,尽管所有患者都有发育迟缓伴智力残疾,并且大多数在儿童后期出现行为问题并患有癫痫发作。
导致功能丧失的[基因名称未给出]变异可导致严重智力残疾,伴或不伴有癫痫发作,这与单倍体不足机制一致。致病性错义突变通过使蛋白质结构域不稳定起作用,使其易于聚集或降解。早期癫痫发作的有无可能反映了文献中的确诊偏倚以及DDD研究的广泛招募策略。